NCT05843539 2025-07-22
CAPONE
University of Lorraine
Completed
Clinical Trials
8 trialsNCT04382352 2023-03-24
B002-101
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 1 Completed
NCT02529930 2022-07-13
An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)
Nykode Therapeutics ASA
Phase 1/2 Completed
NCT04436133 2022-05-06
Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
National Vaccine and Serum Institute, China
Phase 2 Completed
NCT01974869 2017-02-07
Anti Tumor Necrosis Factor Alpha Agents and Surgical Stress Response
El-Hussuna, Alaa, M.D.
Completed
NCT02806934 2016-06-21
TNF Polymorphism and Implantation Rate
Centre Hospitalier Universitaire de Nice
Completed
NCT01349647 2016-01-05
Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01250314 2012-07-03
OSTEHOM
Assistance Publique - Hôpitaux de Paris
Phase NA Completed